TNFRSF4 Antikörper (AA 101-200) (Cy7)
-
- Target Alle TNFRSF4 Antikörper anzeigen
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Bindungsspezifität
- AA 101-200
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TNFRSF4 Antikörper ist konjugiert mit Cy7
-
Applikation
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))
- Kreuzreaktivität
- Human, Maus, Ratte
- Homologie
- Dog,Cow,Horse
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human TNFRSF4
- Isotyp
- IgG
- Top Product
- Discover our top product TNFRSF4 Primärantikörper
-
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) (AA 29-214) antibody
TNFRSF4 Reaktivität: Human WB, FACS, ELISA, IHC, ICC, Neut Wirt: Maus Monoclonal 3G5G7 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) (AA 59-205) antibodyTNFRSF4 Reaktivität: Human, Schimpanse FACS, ELISA, IHC, IF, Coat, ISt, StM Wirt: Maus Monoclonal OX40-3108 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) antibody (PE)TNFRSF4 Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal Ber-ACT35 PE
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) antibody (FITC)TNFRSF4 Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal Ber-ACT35 FITC
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) antibody (APC)TNFRSF4 Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal Ber-ACT35 APC
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) (AA 29-214) antibodyTNFRSF4 Reaktivität: Human WB, FACS, ELISA, IHC, ICC, Neut Wirt: Maus Monoclonal 2D1B8 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) antibodyTNFRSF4 Reaktivität: Human, Non-Human Primate WB, FACS, ELISA, IP, IHC (fro), IHC (p) Wirt: Maus Monoclonal Ber-ACT35 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) (AA 101-200) antibodyTNFRSF4 Reaktivität: Human, Maus, Ratte WB, ELISA, IF (p), IHC (fro), IF (cc), IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) (AA 29-216) antibodyTNFRSF4 Reaktivität: Human FACS, ELISA Wirt: Kaninchen Monoclonal DM116 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) (AA 29-214) antibodyTNFRSF4 Reaktivität: Human WB, FACS, ELISA, IHC, ICC, Neut Wirt: Maus Monoclonal 7B5E10 unconjugated
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
- Andere Bezeichnung
- CD134 (TNFRSF4 Produkte)
- Synonyme
- TNFRSF4 antikoerper, ACT35 antikoerper, CD134 antikoerper, Ly-70 antikoerper, Ox40 antikoerper, TXGP1L antikoerper, Txgp1 antikoerper, OX40 antikoerper, TNF receptor superfamily member 4 antikoerper, tumor necrosis factor receptor superfamily, member 4 antikoerper, TNFRSF4 antikoerper, Tnfrsf4 antikoerper
- Hintergrund
-
Synonyms: OX4, ACT35, CD134, IMD16, TXGP1L, Tumor necrosis factor receptor superfamily member 4, ACT35 antigen, OX4L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, TNFRSF4
Background: Receptor for TNFSF4/OX4L/GP34. Is a costimulatory molecule implicated in long-term T-cell immunity.
- Gen-ID
- 7293
- UniProt
- P43489
- Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-
